| Neurotrophic Bone Marrow Cellular Nests Prevent Spinal Motoneuron Degeneration in Amyotrophic Lateral Sclerosis Patients: A Pilot Safety Study. | |
| | |
MedLine Citation:
|
PMID: 22415951 Owner: NLM Status: Publisher |
Abstract/OtherAbstract:
|
Objective: To assess the safety of intraspinal infusion of autologous bone marrow mononuclear cells (BMNC) and, ultimately, to look for histopathological signs of cellular neurotrophism in amyotrophic lateral sclerosis (ALS) patients. Methods: We conducted an open single arm phase I trial. After six months observation, autologous BMNC were infused into the posterior spinal cord funiculus. Safety was the primary endpoint and was defined as the absence of serious transplant-related adverse events. In addition, forced vital capacity (FVC) and ALS-FRS, MRC and Norris scales were assessed six and three months prior to the transplant and quarterly afterwards for one year. Pathological studies were performed in case of death. Results: Eleven patients were included. We did not observe any severe transplant-related adverse event but there were 43 non-severe events. Twenty-two (51%) resolved in ≤2 weeks and only four were still present at the end of follow-up. All were CTCAE grade ≤2. No acceleration in the rate of decline of FVC, ALS-FRS, Norris or MRC scales was observed. Four patients died on days 359, 378, 808 and 1058 postransplant for reasons unrelated to the procedure. Spinal cord pathological analysis showed a greater number of motoneurons in the treated compared to the untreated segments (4.2+/-0.8 mns/section and 0.9+/-0.3 mns/section, respectively). In the treated segments, motoneurons were surrounded by CD90+ cells and did not show degenerative ubiquitin deposits. Interpretation: This clinical trial confirms not only the safety of intraspinal infusion of autologous BMNC in ALS patients but also provides evidence strongly suggesting their neurotrophic activity. |
| | |
Authors:
|
Miguel Blanquer Blanquer; Jose M Moraleda Jiménez; Francisca Iniesta Martínez; Joaquín Gómez Espuch; José Meca Lallana; Ramón Villaverde González; Miguel Ángel Pérez Espejo; Francisco José Ruíz López; José María García Santos; Patricia Bleda Díaz; Virginia Izura Azanza; María Sáez Gallego; Pedro de Mingo Casado; Laura Vivancos Moreau; Rafael Carles Dies; Judith Jiménez Veiga; Joaquín Hernández Palazón; Julia Guardiola Jiménez; Silvia Torres Del Rio; Carmen Antúnez Almagro; Pedro de la Rosa Jiménez; Maria Juliana Majado Martínez; Andrés Sánchez Salinas; Javier López; Juan Francisco Martínez-Lage Sánchez; Salvador Martínez Pérez |
Publication Detail:
|
Type: JOURNAL ARTICLE Date: 2012-3-13 |
Journal Detail:
|
Title: Stem cells (Dayton, Ohio) Volume: - ISSN: 1549-4918 ISO Abbreviation: - Publication Date: 2012 Mar |
Date Detail:
|
Created Date: 2012-3-14 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 9304532 Medline TA: Stem Cells Country: - |
Other Details:
|
Languages: ENG Pagination: - Citation Subset: - |
Copyright Information:
|
Copyright © 2012 AlphaMed Press. |
Affiliation:
|
Hospital Virgen de la Arrixaca. Universidad de Murcia, Hematopoietic progenitors transplant and cell therapy unit. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Mesoporous Au/TiO(2) Nanocomposite Microspheres for Visible-Light Photocatalysis.
Next Document: Bis(imidazolium) L-Tartrate: A Hydrogen-Bonded Displacive-Type Molecular Ferroelectric Material.